Søs Skovsø, PhD
banner
sisvalkyrielifesci.bsky.social
Søs Skovsø, PhD
@sisvalkyrielifesci.bsky.social
Contract Researcher | Diabetes Research | Former PDF, UBC | Former PhD Candidate, Novo Nordisk & Uni of Copenhagen | Founder of Valkyrie Life Sciences | Scientific Admin for the Breakthrough T1D Centre of Excellence at UBC | Islets |Beta Cells | T1D | T2D
Reposted by Søs Skovsø, PhD
Excited to share the 3rd first-author paper from my PhD! A big thank you to everyone who participated, and to CIHR and Breakthrough T1D Centre of Excellence at UBC for funding! More details below...
www.biorxiv.org/content/10.1...
A prioritized medium-throughput screen on human stem cell derived insulin secreting beta cells identifies FGF4, FGF5, FGF8F, FGF19 and FGF21 as protective factors
Insulin is produced by pancreatic β cells, whose dysfunction and death are hallmarks of diabetes. Stem cell-derived β-like cells (SCβ cells) are a potential alternative to cadaveric islets for replace...
www.biorxiv.org
February 18, 2025 at 2:41 AM